13
Feb

Lexington, MA’s Concert Pharmaceuticals picked up $84 million in an upsized IPO, taking advantage of a prolonged boom for biotechs to replenish its R&D fund.

…read more

Source: Biotech IPOs roll on with Concert’s $84M aria

    

0 No comments